D
emand for cancer care is increasing rapidly in the United States (1-3). More than 1.6 million new cases of cancer are diagnosed each year, and an aging population is expected to contribute to a 45% increase in cancer incidence by 2030 (1) . Advances in diagnostic and treatment methods, coupled with increasing competition in the cancer care market, mean that a growing number of patients with cancer face a large array of therapeutic options. In 2012, more than 1500 cancer programs were accredited by the American College of Surgeons, and this number continues to grow (4) .
More cancer centers in the United States market their clinical services directly to the public through advertising (5, 6) . A recent survey of 348 patients with cancer reported that 86% were aware of cancer-related advertisements, particularly for products and services related to their cancer types (7) . The ethical implications of such advertising have been subject to debate (8) . Proponents argue that health care advertising provides valuable information to the public about screening and treatment options, thereby furthering patient-centered care (9) . Critics express concerns that health care advertising may exaggerate therapeutic benefits and drive inappropriate demands for clinical services, which contributes to rapidly escalating health care costs (10 -12) . These concerns may be particularly heightened for cancer centers because patients with advanced cancer often overestimate the potential benefits they will receive from new treatments or their chance for cure (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) .
Misleading, emotionally charged, or incomplete promotional claims in cancer center advertisements could contribute to widespread misperceptions about cancer care.
However, to our knowledge, there has been no empirical examination of the content of cancer center advertisements to date. An understanding of advertising content is necessary to inform future investigations of its effect. Therefore, we conducted a systematic content analysis of cancer center advertisements for clinical services. Our aim was to describe the types of clinical services promoted, the amount of information provided about these services, and the use of emotional advertising appeals and patient testimonials. We further sought to describe whether informational and emotional advertising content differed by type of cancer center.
sumer magazines and on television networks in the United States in 2012. We chose to examine magazine and television advertisements because patients with cancer report being most frequently aware of advertising in these media markets (7).
Data Sources
We obtained all advertisements from Kantar Media (New York, New York), an independent media-monitoring agency that tracks and electronically archives local and national advertisements in the top 269 U.S. consumer magazines and on 44 television networks (total audience of 115 810 740 persons in 2012). Kantar Media provided full content (in JPEG format for magazine advertisements and audio-video interleaved format for television advertisements) for every cancer center advertisement in 2012.
In addition, we collected information about cancer centers to characterize our study sample: National Cancer Institute (NCI) designation status (obtained from the NCI Web site [25] ), Commission on Cancer accreditation status (obtained from the American College of Surgeons Web site [26] ), tax-exemption status (verified by calling the number listed on each cancer center's Web site), and number of facilities per center and regional location (obtained from each cancer center's Web site).
Inclusion and Exclusion Criteria
We included unique cancer center advertisements for clinical services in 2012. Duplicate advertisements, advertisements that were related to cancer but did not promote a cancer center, and advertisements that were not in English or for which the full-length content was not available were excluded. After full-content review of remaining advertisements, we further excluded advertisements that were only public service announcements; included only the cancer center name, image, or slogan without a description of clinical services; included only a provider profile without a description of clinical services; or described only fundraising, employment, or research opportunities.
Codebook Development
Our multidisciplinary team developed a standardized codebook to categorize advertising content. We developed all coding categories a priori on the basis of content analyses of health care advertisements in other contexts (27) (28) (29) and advertising principles from the marketing field (30) . Our codebook encompassed 4 domains: types of clinical services promoted, information provided about advertised services, use of emotional advertising appeals, and use of patient testimonials and disclaimers.
We categorized types of advertised services as cancer treatments (including chemotherapy, radiation therapy, and surgical interventions), cancer screening (for example, mammography or colonoscopy) or supportive services (including nutritional services, complementary and alternative therapies, spiritual services, psychosocial services, physical or occupational therapy, and palliative care). Within each category, we also coded whether the type of clinical service was specified (such as "Novac7 Intraoperative Radiation Therapy" [Hitesys, Aprilia, Italy]) or unspecified (for example, "a combination of complex therapies").
We assessed whether information was provided about the indication (cancer type and stage), benefits (any description of a potential positive outcome), risks (any description of a potential negative outcome), alternatives, costs, and insurance availability of advertised services. We further categorized information about benefits and risks as qualitative (for example, "CyberKnife [Accuray, Sunnyvale, California] targets and destroys tumors throughout the body.") or quantitative (for example, "If [breast cancer] is caught early, 98% will survive 5 years."). We designated any text that mentioned the costs of services or potential insurance coverage as a description of costs (for example, "In-network with most major tri-state area health plans.").
We coded for emotional appeals related to survival or potential for cure and comfort, quality of life, or patientcentered care. We created subcodes within each category to further classify persuasive advertising techniques that have been described in other contexts (27, 28, 30) . For example, if advertisements were related to survival or potential for cure, we specifically assessed for descriptions of hope, survival, or cure; death, disability, or fear; advanced technology; fighting cancer; relentless cancer care; and medical miracles. If advertisements were related to comfort, quality of life, and patient-centered care, we specifically assessed for descriptions of individualized care; comfort, compassion, symptom management, or quality of life; and involvement of patients and families in decision making.
Context
Direct-to-consumer advertising by cancer centers has increased. The ethics of such advertising has been debated.
Contribution
An analysis of direct-to-consumer advertisements placed by cancer centers concludes that most advertisements evoke hope for survival and promote innovative therapies but do not generally address actual benefits, risks, or costs. Patient testimonials did not generally include disclaimers, despite Federal Trade Commission mandates that require them.
Caution
The effect of advertisements on the treatment choices of patients was not assessed.
Implication
Direct-to-consumer advertisements placed by cancer centers are based on emotional appeals and generally do not provide information on all aspects of care that may be important to patients.
-The Editors
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We defined a patient testimonial as any endorsement of the cancer center by a named patient, including local or national celebrities. For advertisements that included patient testimonials, we assessed whether a disclaimer was included (defined as any mention of whether results were typical or whether viewers may expect to see similar results). If a disclaimer was present, we assessed whether a description of typical results that a viewer may expect was included (31) .
The complete codebook, including definitions and representative examples, is included in the Supplement (available at www.annals.org).
Statistical Analysis
Two coders independently coded all advertisements by using ATLAS.ti 7 (ATLAS.ti Scientific Software Development, Berlin, Germany), a qualitative data analysis software program with multimedia capability. All questions that arose during individual coding were brought to the team for discussion and resolution by consensus. Both coders independently coded a subset of 20 advertisements (10 each for magazine and television), and a value was calculated for each code to assess interrater reliability. We used simple descriptive statistics to summarize the data and compare for differences in content between NCI-and non-NCI-designated centers.
Role of the Funding Source
This project was funded by the National Institutes of Health. The funding source had no role in study design, conduct, or analysis.
RESULTS
Out of 1427 advertisements placed between 1 January and 31 December 2012, 1018 were excluded (Figure 1) , which left 409 unique advertisements that promoted clinical services at 102 cancer centers.
Eighty-seven cancer centers placed clinical advertisements on television, 28 cancer centers placed clinical advertisements in magazines, and 13 cancer centers advertised in both media markets. The mean number of unique magazine advertisements per institution was 3 (range, 1 to 18), and the mean number of unique television advertisements per institution was 3.7 (range, 1 to 45).
Characteristics of centers that placed clinical advertisements are shown in Table 1 . Most centers were for-profit (60%), and 16% were NCI-designated.
Coding of advertisements proceeded without difficulty. The values for our main findings ranged from 0.77 to 1.00, indicating excellent interrater reliability.
Types of Clinical Services
The specific types of clinical services advertised are presented in Table 2 
Information About Clinical Services
Information provided about clinical services is shown in Figure 2 . Fifty-seven percent of advertisements (235 out of 409) indicated a specific type of cancer (for example, "devoted exclusively to women fighting breast cancer"), whereas only 9% (38 out of 409) indicated the stage of cancer (such as "complex and late-stage cancer") targeted by advertised therapies. Fewer than 2% of advertisements (7 out of 409) mentioned an alternative to the advertised service (for example, "CyberKnife may be an alternative to surgery." or "Breast brachytherapy is a 5-day alternative to 6 weeks of radiation."). More than 25% of advertisements (109 out of 409) mentioned potential benefits of advertised therapies (for example, "The da Vinci System [Intuitive Surgical, Sunnyvale, California] offers a shorter hospital stay and less chance of needing follow-up surgery."), but only 2% (8 out of 409) quantified these benefits. Less than 2% of advertisements (7 out of 409) mentioned the possibility of risks from treatment (for example, "a low risk of incontinence and impotence"), and no advertisements quantified the level of potential risks. Only 5% of advertisements (21 out of 409) mentioned costs or coverage of advertised treatments. No advertisements mentioned availability under specific insurance plans.
Emotional Appeals
Eighty-five percent of advertisements (347 out of 409) included emotional appeals ( Table 3) . Emotional appeals were more commonly related to survival or potential for cure (347 [85%]) rather than comfort, quality of life, or patient-centered care (177 [43%]).
Sixty-one percent of advertisements (248 out of 409) used language that evoked hope (for example, "your last hope" or "Our advanced care adds another dimension to cancer care. Hope."). More than 40% of advertisements (167 out of 409) described cancer as a fight or battle (for example, "Knocking out cancer" or "I fought, I won."), 30% (123 out of 409) evoked fear (such as, "I didn't know if anyone survived pancreatic cancer."), and 19% suggested unrelenting care (for example, "care that never quits"). More than one half of advertisements (211 out of 409) mentioned technological innovations or treatment advances (for example, "Introducing TomoTherapy [Accuray, Sunnyvale, California], the most advanced treatment available."), and 6% (24 out of 409) evoked medical miracles (for example, "beyond extraordinary").
Fewer than one third of advertisements (106 out of 409) highlighted patient comfort, compassion, symptom management, or quality of life (for example, "We provide options to make the treatment time more comfortable." or "We're dedicated to not only providing the best treatment, but the best quality of life at every turn."). Thirty-one percent of advertisements (127 out of 409) mentioned that the treatment or experience would be tailored to meet patients' needs (for example, "personalized care in a comfortable environment" or "Our patients are unique. So are Radiation therapy (e.g., "brachytherapy," "TomoTherapy," or "CyberKnife")
109 (27) Surgical intervention (e.g., "robotic-assisted laparoscopic prostatectomy")
(15)
Chemotherapy 30 (7) Other or combined cancer therapy (e.g., "Novac7
Intraoperative Radiation Therapy")
(7)
Cancer screening services 75 (18) Cancer screening or imaging (e.g., "PET/CT scan," "3DCT," or "ductoscopy")
(18)
Supportive services 53 (13) Nutritional services (e.g., "We help cancer patients maintain nutritional diets.")
(6)
Complementary and alternative medicine (e.g., "acupuncture" or "yoga")
(5)
Spiritual or religious services (e.g., "daily interfaith worship services")
(4)
Psychosocial services (e.g., "psychological counseling")
(2)
Physical or occupational therapy (e.g., "rehabilitation")
Supportive/palliative care (e.g., "pain management") 8 (2) Nonspecified supportive services (e.g., "a number of supportive services")
(4)
CT ϭ computed tomography; PET ϭ positron emission tomography; 3DCT ϭ 3-dimensional computed tomography. * Individual advertisements may promote several types of clinical services. Mention cancer type 57
Original Research Content Analysis of Cancer Center Advertisements their tumors."). Six percent of advertisements (25 out of 409) discussed involvement of patients or family members in medical decision making (for example, "I was part of the decision-making team." or "They offered me advice about treatments, but the decision was always mine.").
Testimonials
Nearly one half of advertisements (181 [44%]) for clinical services included endorsements from patients with cancer, and a few (21 [5%]) included endorsements from local or national celebrities. Testimonials overwhelmingly focused on stories about survival or cure (143 out of 181 [79%]) (for example, "I used to think that you had to go to NYC for anything serious, but after my experience, I don't know why anyone would go anywhere but the [X cancer center]. They saved my life." or "My doctor back home gave me ONLY a few weeks to live. That's when I made the ONE decision that saved my life. I went to [X cancer center]. That was seven years ago. And counting." Only 15% of testimonials (27 out of 181) included a disclaimer (for example, "Most patients do not experience these results."). No advertisements described the outcome that a typical patient may expect.
Comparison of Advertising Content by Cancer Center Type
Comparison of advertising content by NCI center designation is shown in Table 4 . Advertisements placed by NCI-designated centers were less likely than those placed by non-NCI-designated centers to promote cancer treatments (81% vs. 90%) or supportive services (6% vs. 15%). Description of risks, benefits, and alternatives occurred with similar frequency. However, NCI-designated advertisements were more likely to mention costs or coverage of services (12% vs. 3%). Testimonials and emotional appeals related to survival were more frequent among NCIdesignated center advertisements. Use fighting language Describes cancer as a fight or battle ("Winning the war against cancer"; "I can kick this"; or "I fought, I won.")
167 (41) Evoke fear Mentions death, disability, fear, or loss ("When David was diagnosed with cancer in his chest, he felt like he was losing everything.")
(30)
Unrelenting care Describes treatment that does not stop until cancer is cured or cancer in general is eliminated ("Making history" or "Care that never quits") 78 (19) Medical miracles Describes cancer treatment or center as miraculous, remarkable, or extraordinary ("Extraordinary results")
(6)
Focus on comfort, quality of life, or patient-centered care Individualized care
States that treatment or experience will be tailored to meet patients' needs ("I'm remembered by my name, not as a number." or "Our patients are unique. So are their tumors.")
(31)
Highlight comfort or describe quality of life Mentions comfort, compassion, symptom management, or quality of life ("We're dedicated to not only providing the best treatment, but the best quality of life at every turn.")
(26)
Shared decision making Discusses involvement of patients or family members in medical decision making ("They offered me advice about treatments, but the decision was always mine.")
25 (6) * Individual advertisements may be coded for several persuasion techniques. 
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DISCUSSION
In a systematic content analysis of 409 advertisements for clinical services placed by 102 cancer centers in the United States in 2012, we found that cancer therapies were promoted more commonly than supportive or screening services and were often described in vague or general terms. Advertisements commonly evoked hope for survival, promoted innovative treatment advances, and used language about fighting cancer while providing relatively limited information about benefits, risks, costs, or insurance coverage of advertised therapies. Patient testimonials focused on survival and rarely included disclaimers.
To our knowledge, this is the first comprehensive analysis of the content of cancer center advertising. However, our findings are consistent with a previous analysis of advertising among top U.S. hospitals, which also found frequent use of emotional appeals and scarce mention of risk of services or quantification of benefit (27) . Our sample included both for-profit and nonprofit cancer centers, as well as a substantial percentage of cancer centers with more prominent credentials (approximately 5% of cancer centers nationally are NCI-designated, whereas 16% of centers that placed clinical advertisements in 2012 had this designation). Of interest, we found that NCI-designated centers more frequently used emotional appeals related to survival or potential for cure. Although these centers mentioned costs or coverage of treatment more commonly, they omitted information about risks, benefits, and alternatives with similar frequency as non-NCI-designated centers. These findings suggest that emotional appeals coupled with incomplete information are being widely used to promote services, even among the nation's most prestigious cancer centers.
The use of emotion can be an effective and powerful means of persuasion (32) . Information-based strategies present viewers with evidence (such as benefits, risks, or costs of products or services) and persuade by the force of logic. In contrast, emotional appeals persuade viewers by creating feelings of empathy for the characters or by associating the brand with feelings of warmth and hope (33) . Fear appeals persuade an audience by presenting negative consequences (for example, progression of cancer or death) and subsequently providing a solution to the undesirable outcome (for example, receiving cancer treatment at a specific location) (30, 34, 35) . The use of emotional appeals has several persuasive advantages over reasoning strategies: It does not raise consumers' normal defenses, it requires less effort from the viewer, and it increases viewer recall of advertised products or services (32, 36, 37) . Research has shown that highly emotional advertisements have been more effective in changing behavior for cancer screening and smoking cessation when compared with low-emotion or logic-based advertisements (38, 39) . Emotional appeals have also been used to advertise genetic tests, self-referred imaging services, and prescription medications (40 -42).
Given the inherently frightening nature of cancer, it may be impossible for cancer centers to advertise without affecting viewers' emotions to some degree. However, clinical advertisements that use emotional appeal uncoupled with information about indications, benefits, risks, or alternatives may lead patients to pursue care that is either unnecessary or unsupported by scientific evidence. Pursuit of unnecessary tests or treatment may, in turn, expose patients to avoidable risks and contribute to increasing costs for patients and the health care system (43) . Advertisements that omit information about costs or insurance coverage may lead to distress if services prove unaffordable. Further research is needed to identify the extent (if any) to which cancer center advertising contributes to rapidly escalating costs of cancer care in the United States.
The dominant narrative of survival in cancer center advertising must be considered in light of well-described overestimations of curability and treatment benefit among patients with cancer (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . Although efforts to explain patients' false hope have traditionally focused on psychological needs or inadequate communication with physicians (44 -46), advertising testimonials about potential cure may also play a role. To the extent that such advertisements generate inaccurate expectations of treatment benefit, they may complicate provider-patient discussions about prognosis and appropriate therapeutic options. Although the Federal Trade Commission recently mandated that testimonials include disclaimers and a description of results that a typical patient may expect to see (31), we found only limited evidence of this practice.
Our study has several limitations. First, we analyzed only magazine and television advertisements. Our findings may not generalize to cancer center advertisements in other types of media, such as the Internet, newspapers, radio, or billboards. Second, we obtained advertising content from a media-monitoring agency that tracks advertisements on the basis of the advertiser, content, and date. Although health care researchers commonly use this search strategy (27, 47, 48) , it is possible that advertisements that met our inclusion criteria were not obtained. However, given the agency's expertise and software capabilities, we have a high level of confidence in the search results. Third, our search strategy provided advertising content from 102 cancer centers. Although these centers represent all regions in the United States, they may not be representative of cancer centers nationally. For example, our sample consisted of more NCI-designated centers than the national sample (16% vs. approximately 5%) and fewer centers accredited by the Commission on Cancer (59% vs. 70%). Fourth, our search strategy did not provide information on whether advertisements were placed in national versus regional markets. Fifth, as with other content analyses, our assessment of advertisements involved creating codes to classify data. We attempted to maximize objectivity by developing an extensive codebook with definitions and examples informed by
Original Research Content Analysis of Cancer Center Advertisements previously defined advertising techniques, and our calculation demonstrated excellent interrater reliability. Sixth, the nature of this analysis did not allow us to directly examine the effect of advertising content on patients.
In summary, we found that clinical advertising by cancer centers frequently promoted cancer therapy by using emotional appeals that evoked hope and fear while providing relatively little substantive information about risks, benefits, indications, or costs. Further work is needed to understand how cancer center advertisements influence viewer preferences and patients' expectations of benefit from cancer treatments.
